Clinical Trials Logo

Rheumatoid Arthritis clinical trials

View clinical trials related to Rheumatoid Arthritis.

Filter by:

NCT ID: NCT05289544 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Phone-Based Based Walk With Ease Program for Adults With Arthritis

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to examine the short-term (6-weeks and 6 months) and long-term (1 year) effects of a phone-based version of Walk With Ease intervention.

NCT ID: NCT05283096 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Survey About Diet in Chronic Inflammatory Rheumatic Diseases

Start date: February 10, 2022
Phase:
Study type: Observational

A French Survey on patients' practices, knowledge and beliefs about diet in chronic inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, spondylarthritis) Use of a questionnaire about what patients have heard concerning diet and rheumatism, what kind of diet they tried eventually and how it affected their health and disease

NCT ID: NCT05246280 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Start date: March 2, 2022
Phase: Phase 3
Study type: Interventional

This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα therapy.

NCT ID: NCT05197036 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

A Global Clinical Study Investigating the Safety and Effectiveness of Smith and Nephew's Porous Knee System in Patients Who Need a Total Knee Replacement Due to Degenerative Arthritis, Post-traumatic Arthritis or Inflammatory Arthritis

Start date: December 21, 2021
Phase:
Study type: Observational

A clinical trial investigating the safety and effectiveness of Smith and Nephew's FDA-approved Porous Total Knee System, which is used to replace worn away and diseased knee joints. The aim of this study is to show that most patients who receive the Porous Total Knee System have reduced pain, greater mobility and a long-lasting implant post-surgery.

NCT ID: NCT05152615 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA)

Start date: November 17, 2021
Phase: N/A
Study type: Interventional

This study is a pilot, proof of concept study to determine the effects of administering an oral short chain fatty acid (SCFA) supplement along with methotrexate as first line treatment of new onset rheumatoid arthritis (NORA) patients. Up to 50 participants will be included to obtain a sample size of at least 16 participants taking the oral supplement. The study team hypothesizes that oral SCFA will change the participants' gut microbiome and regulatory immune responses. Clinical data to assess for adverse events, stool, urine samples and peripheral blood will be collected at baseline, 2 and 4 months with an optional 6-month time point. Fecal microbiome will be analyzed. Adaptive immune responses will be analyzed from participant blood samples.

NCT ID: NCT05144191 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Insignia™ Hip Stem Outcomes Study

Start date: February 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the safety and effectiveness of the Insignia™ Hip Stem for global market access and post-market clinical follow-up up to 10 years postoperative.

NCT ID: NCT05116163 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology

Start date: June 17, 2022
Phase: N/A
Study type: Interventional

The first aim of this study is to test the efficacy of a real-time provider-based individuation intervention to improve the receipt of high-quality rheumatic disease care among Black/African American and lower socioeconomic status (SES) individuals. The second aim is to determine the effect of the individuation intervention on provider-patient communication, adherence, provider trust and care satisfaction.

NCT ID: NCT05082805 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis

STRATEGE2
Start date: February 25, 2019
Phase:
Study type: Observational

This is a longitudinal, observational, prospective, multicentre study conducted in France, among a representative sample of rheumatology doctors. The aim of this study is to describe in real life the therapeutic strategy when faced with a patient with rheumatoid arthritis (RA) or psoriatic arthritis (PsA) who requires initiation of treatment with biotherapy or targeted therapy. The evolution of the disease and the possible therapeutic adaptations will then be followed for 2 years.

NCT ID: NCT05045898 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

The Effect of Plantar Massage and Textured Insoles on Balance in Rheumatoid Arthritis

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to determine and compare the effects of using textured insoles and plantar massage on balance in patients with rheumatoid arthritis. Patients diagnosed with rheumatoid arthritis will be divided into two groups. In the first group the patients will be given plantar massage; in the second group, both plantar massage will be applied and the patients will use textured insoles in their indoor and outdoor activities. Plantar massage will be applied by the physiotherapist 3 days a week for 6 weeks; textured insoles will also be used for 6 weeks. All patients will be asked to complete the questionnaires, which assessed foot functionality, physical activity levels and quality of life. After each patients completed the questionnaire, the physiotherapist will perform plantar sensory and balance assessment. All assessments will be made before, after and 8 weeks after treatment.

NCT ID: NCT05002959 Active, not recruiting - Clinical trials for Rheumatoid Arthritis

TESS V3 Modular Total Shoulder System PMCF

Start date: February 1, 2022
Phase:
Study type: Observational

This is a multicenter, retrospective and prospective, non-controlled post market surveillance study. The objectives of this study are to confirm safety, performance and clinical benefits of the T.E.S.S.® Version 3 Anatomic and Reverse Modular Total shoulder prosthesis and its instrumentation.